SCHEMBL7047356

SCHEMBL7047356

C=CCc1cc(Cl)cc(-n2nc(-c3ccc(Br)s3)[nH]c2=O)c1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044883 0.88 KDM4E (0.30)
SCHEMBL7045437 0.85 CNR1 (0.34)
SCHEMBL7039920 0.85 F10 (0.31)
SCHEMBL7039146 0.84 CNR1 (0.32)
SCHEMBL7042358 0.78 LMNA (0.41)
SCHEMBL7043464 0.74 CNR1 (0.34)
SCHEMBL7042344 0.74 AMY1A (0.36)
SCHEMBL7042374 0.74 CNR1 (0.35)
SCHEMBL3765374 0.73 NR1I2 (0.38)
SCHEMBL7045461 0.73 NR1I2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613786-B2 Treating urinary incontinence, asthma, irritable bowel syndrome or male erectile dysfunction BRISTOL-MYERS SQUIBB COMPANY 2003-09-02 US disclosed
US-20030144333-A1 Thiophenyl triazol-3-one derivatives as smooth muscle relaxants HEWAWASAM PIYASENA (US) 2003-07-31 US disclosed